Loading...
Symbols:
Loading...
Symbols:
Novo Nordisk A/S (NVO)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Novo Nordisk A/S (NVO)
34 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on NVO
- Mike Huckman(8)
- ChinaBio Today(6)
- SA Editor Miriam Metzinger(4)
- SA Editor Joan Wickham(4)
- RJ Steffens (3)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(387)
- Stockerblog (168)
- SA Editor Joan Wickham(145)
- SA Editor Miriam Metzinger(119)
- Mike Havrilla(105)
Most commented on authors
- RJ Steffens (20)
- Keith Robison(11)
- SA Editor Joan Wickham(10)
- Mike Huckman(9)
- Mike Havrilla(5)
- Nine Pharma Predictions for 2009
- China Biopharma News Back in the Spotlight
- Big Pharma Steps Up China Investment
- What Are Some of the Best Hedge Fund Managers Doing?
- Novo Nordisk: Approval of New Diabetes Drug Is Further Postponed
- China Biotech in Review: Earnings Week
- Novo Nordisk Expands R&D Presence in China with New Manufacturing Plant
- Bullish Outlook for Preventive Medicine Companies Reflected in New ETF
- The Market Is Weak - Fast Money Recap (9/8/08)
- AstraZeneca Gives FluMist Spray a Shot in the Arm
- Four Drug Companies Vying for Diabetes Patients
- NordiCaps Regional Stock Index: Tracking Scandinavia's Finest
- Credit Suisse Healthier 15: Investors Get the Skinny on Fat Fighters
- Diabetes Stocks Remain Healthy
- Is Lilly and Amylin's Byetta Better?
- ADA's 68th Scientific Sessions: A New Look at Insulin Therapy
- Fast Money Recap - Oil Spoils Everything (6/6/08)
- Analyst Notes: Lilly Gets A Lift, Pfizer Goes Pfft
- Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
- Generex Biotech's Oral-lyn Granted Special Access Authorization by Health Canada
- Biotech in Review: Investment Capital for China Biopharma
- Novo Nordisk Donates Compound Library to China Center
- European Dividend Aristocrats: The Top Growers
- Inhaled Insulin: Eli Lilly On Its 'Last Breath'?
- Eat It, Breathe It, Soak in It? Drug Administration Gets Tricky
- Shares of Novo Nordisk Rise on Diabetes Drug Data
- Eight Danish Stocks to Add to Your Portfolio
- Novo Nordisk: Doing Nicely
- Biotech Generics: Who Stands Where? - Barron's
- Novo Nordisk: Set to Conquer the Insulin Market - Barron's
- Top Six Socially Responsible Healthcare and Pharmaceutical Firms
- Barron’s Tepid Review of Amylin Pharmaceuticals (AMLN, PFE, NKTR, SNY, NVO)
- Diabetes Market Heating Up: Novo Nordisk Releases Positive Liraglutide Data (AMLN, NVO)
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »
1 new today)